{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:20:20Z","timestamp":1794918020971,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74419-9","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:23:52Z","timestamp":1781641432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A preoperative Artificial Intelligence model to estimate cancer-specific mortality in nonmetastatic kidney cancer patients"],"prefix":"10.1038","volume":"17","author":[{"given":"Alessandro","family":"Larcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6183-4429","authenticated-orcid":false,"given":"Alberto","family":"Traverso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Scuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Musso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Canibus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Caivano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Zambello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8488-7991","authenticated-orcid":false,"given":"Marco","family":"Denti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5237-0888","authenticated-orcid":false,"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Serni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Granata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Vignale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-6266","authenticated-orcid":false,"given":"Antonio","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-000X","authenticated-orcid":false,"given":"Carlo","family":"Tacchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-7165","authenticated-orcid":false,"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"74419_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"74419_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrurol.2015.232","volume":"12","author":"I Lucca","year":"2015","unstructured":"Lucca, I., Klatte, T., Fajkovic, H., de Martino, M. & Shariat, S. F. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat. Rev. Urol. 12, 585\u2013592 (2015).","journal-title":"Nat. Rev. Urol."},{"key":"74419_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","volume":"88","author":"A Larcher","year":"2025","unstructured":"Larcher, A. et al. Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors. Eur. Urol. 88, 341\u2013358 (2025).","journal-title":"Eur. Urol."},{"key":"74419_CR4","doi-asserted-by":"publisher","first-page":"2178217","DOI":"10.1080\/21645515.2023.2178217","volume":"19","author":"P Dibajnia","year":"2023","unstructured":"Dibajnia, P., Cardenas, L. M. & Lalani, A. K. A. The emerging landscape of neo\/adjuvant immunotherapy in renal cell carcinoma. Hum. Vaccines Immunotherapeutics 19, 2178217 (2023).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"74419_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.eururo.2025.01.007","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex, A. et al. A call for a neoadjuvant kidney cancer consortium: lessons learned from other cancer types. Eur. Urol. 87, 385\u2013389 (2025).","journal-title":"Eur. Urol."},{"key":"74419_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2022.01.043","volume":"81","author":"MI Carlo","year":"2022","unstructured":"Carlo, M. I. et al. Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy. Eur. Urol. 81, 570\u2013573 (2022).","journal-title":"Eur. Urol."},{"key":"74419_CR7","doi-asserted-by":"publisher","first-page":"853.e1","DOI":"10.1016\/j.urolonc.2020.07.019","volume":"38","author":"R Mano","year":"2020","unstructured":"Mano, R. et al. Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. Urol. Oncol. 38, 853.e1\u2013853.e7 (2020).","journal-title":"Urol. Oncol."},{"key":"74419_CR8","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00345-022-04153-6","volume":"40","author":"G Fallara","year":"2022","unstructured":"Fallara, G. et al. How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? World J. Urol. 40, 2667\u20132673 (2022).","journal-title":"World J. Urol."},{"key":"74419_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.eururo.2022.10.010","volume":"83","author":"J Bedke","year":"2023","unstructured":"Bedke, J. et al. The 2022 updated european association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma. Eur. Urol. 83, 10\u201314 (2023).","journal-title":"Eur. Urol."},{"key":"74419_CR10","unstructured":"Marandino L., et al. Neoadjuvant and adjuvant immune-based approach for renal cell carcinoma: pros, cons, and future directions. Eur. Urol. Oncol. 25, S2588-931100211-6 (2024)."},{"key":"74419_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.euo.2024.03.014","volume":"7","author":"C Cerrato","year":"2024","unstructured":"Cerrato, C. et al. Effect of sex on the oncological outcomes in response to immunotherapy and antibody-drug conjugates in patients with urothelial and kidney cancer: a systematic review and a network meta-analysis. Eur. Urol. Oncol. 7, 1005\u20131014 (2024).","journal-title":"Eur. Urol. Oncol."},{"key":"74419_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier, B. et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30, 706\u2013720 (2019).","journal-title":"Ann. Oncol."},{"key":"74419_CR13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.euf.2020.06.024","volume":"7","author":"H Harrison","year":"2021","unstructured":"Harrison, H. et al. Risk prediction models for kidney cancer: a systematic review. Eur. Urol. Focus 7, 1380\u20131390 (2021).","journal-title":"Eur. Urol. Focus"},{"key":"74419_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.2474","volume":"111","author":"CA Purpura","year":"2022","unstructured":"Purpura, C. A., Garry, E. M., Honig, N., Case, A. & Rassen, J. A. The role of real-world evidence in FDA-approved new drug and biologics license applications. Clin. Pharm. Ther. 111, 135\u2013144 (2022).","journal-title":"Clin. Pharm. Ther."},{"key":"74419_CR15","doi-asserted-by":"crossref","unstructured":"Wee, L. et al. Reporting Standards and Critical Appraisal of Prediction Models. In: Kubben P., Dumontier M., Dekker A., curatori. Fundamentals of Clinical Data Science [Internet]. Cham: Springer International Publishing; 2019 [citato 14 ottobre 2024]. p. 135\u2013150. Disponibile su: http:\/\/link.springer.com\/10.1007\/978-3-319-99713-1_10.","DOI":"10.1007\/978-3-319-99713-1_10"},{"key":"74419_CR16","doi-asserted-by":"crossref","unstructured":"Van, K. S. M. J., Dankers, F. J. W. M., Traverso, A. & Wee L. Preparing data for predictive modelling. In: Kubben P., Dumontier M., Dekker A., curatori. Fundamentals of Clinical Data Science [Internet]. Cham: Springer International Publishing; 2019 [citato 6 novembre 2024]. p. 75\u201384. Disponibile su: http:\/\/link.springer.com\/10.1007\/978-3-319-99713-1_6.","DOI":"10.1007\/978-3-319-99713-1_6"},{"key":"74419_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur, M. J., Stuart, E. A., Frangakis, C. & Leaf, P. J. Multiple imputation by chained equations: what is it and how does it work? Int. J. Methods Psychiatr. Res. 20, 40\u201349 (2011).","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"74419_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","volume":"83","author":"RJA Little","year":"1988","unstructured":"Little, R. J. A. A test of missing completely at random for multivariate data with missing values. J. Am. Stat. Assoc. 83, 1198\u20131202 (1988).","journal-title":"J. Am. Stat. Assoc."},{"key":"74419_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-02016-z","volume":"22","author":"G Shan","year":"2022","unstructured":"Shan, G. Monte Carlo cross-validation for a study with binary outcome and limited sample size. BMC Med Inf. Decis. Mak. 22, 270 (2022).","journal-title":"BMC Med Inf. Decis. Mak."},{"key":"74419_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1213\/ANE.0000000000003653","volume":"127","author":"P Schober","year":"2018","unstructured":"Schober, P. & Vetter, T. R. Survival analysis and interpretation of time-to-event data: the tortoise and the hare. Anesthesia Analgesia 127, 792\u2013798 (2018).","journal-title":"Anesthesia Analgesia"},{"key":"74419_CR21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","volume":"26","author":"A Altmann","year":"2010","unstructured":"Altmann, A., Tolo\u015fi, L., Sander, O. & Lengauer, T. Permutation importance: a corrected feature importance measure. Bioinformatics 26, 1340\u20131347 (2010).","journal-title":"Bioinformatics"},{"key":"74419_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.procs.2023.03.107","volume":"220","author":"M Louhichi","year":"2023","unstructured":"Louhichi, M., Nesmaoui, R., Mbarek, M. & Lazaar, M. Shapley values for explaining the black box nature of machine learning model clustering. Procedia Computer Sci. 220, 806\u2013811 (2023).","journal-title":"Procedia Computer Sci."},{"key":"74419_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41698-024-00532-x","volume":"8","author":"G Margue","year":"2024","unstructured":"Margue, G. et al. UroPredict: machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120). npj Precis. Onc. 8, 45 (2024).","journal-title":"npj Precis. Onc."},{"key":"74419_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann. Intern. Med. 162, 55\u201363 (2015).","journal-title":"Ann. Intern. Med."},{"key":"74419_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12894-021-00796-6","volume":"21","author":"R Xiao","year":"2021","unstructured":"Xiao, R. et al. Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus. BMC Urol. 21, 31 (2021).","journal-title":"BMC Urol."},{"key":"74419_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V. & Sood, A. K. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell 33, 965\u2013983 (2018).","journal-title":"Cancer Cell"},{"key":"74419_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bju.13670","volume":"120","author":"A Larcher","year":"2017","unstructured":"Larcher, A. et al. When to perform preoperative chest computed tomography for renal cancer staging. BJU Int. 120, 490\u2013496 (2017).","journal-title":"BJU Int"},{"key":"74419_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.urology.2017.08.043","volume":"110","author":"A Larcher","year":"2017","unstructured":"Larcher, A. et al. When to perform preoperative bone scintigraphy for kidney cancer staging: indications for preoperative bone scintigraphy. Urology 110, 114\u2013120 (2017).","journal-title":"Urology"},{"key":"74419_CR29","doi-asserted-by":"publisher","first-page":"154096","DOI":"10.1109\/ACCESS.2019.2949286","volume":"7","author":"O Loyola-Gonzalez","year":"2019","unstructured":"Loyola-Gonzalez, O. Black-box vs. white-box: understanding their advantages and weaknesses from a practical point of view. IEEE Access 7, 154096\u2013154113 (2019).","journal-title":"IEEE Access"},{"key":"74419_CR30","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/cancers13061348","volume":"13","author":"J M\u00fchlbauer","year":"2021","unstructured":"M\u00fchlbauer, J. et al. Radiomics in renal cell carcinoma-A systematic review and meta-analysis. Cancers (Basel) 13, 1348 (2021).","journal-title":"Cancers (Basel)"},{"key":"74419_CR31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","volume":"25","author":"B Shuch","year":"2024","unstructured":"Shuch, B. et al. 89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol. 25, 1277\u20131287 (2024).","journal-title":"Lancet Oncol."},{"key":"74419_CR32","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.19093594","author":"A Larcher","year":"2026","unstructured":"Larcher, A. et al. A preoperative artificial intelligence model to estimate cancer specific mortality in nonmetastatic kidney cancer patients. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19093594 (2026).","journal-title":"Zenodo"}],"updated-by":[{"DOI":"10.1038\/s41467-026-79624-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:00:00Z","timestamp":1794873600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74419-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74419-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:37:05Z","timestamp":1794915425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74419-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74419"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74419-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7651"}}